Nomenclature of HBV core protein-targeting antivirals
Fabien Zoulim(Hôpital de la Croix-Rousse), Harry L.A. Janssen(Erasmus MC), William E. Delaney(Assembly Biosciences (United States)), Jianming Hu(Pennsylvania State University), Michael Nassal(University Medical Center Freiburg), Oliver Lenz(Janssen (Belgium)), Nagraj Mani, Stephanie Buchholz, Veronica Miller(University of California, Berkeley), Eric Donaldson, John Fry(Janssen (United States)), Kai Lin(US Biologic (United States)), Adam Zlotnick(Indiana University Bloomington), Gabriel Westman(Uppsala University), Michael Kann(Sahlgrenska University Hospital), Su Wang(Rutgers, The State University of New Jersey), Anuj Gaggar(Gilead Sciences (United States))
Cited by 67
Related Papers
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
|Gastroenterology|2009|693
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
|New England Journal of Medicine|2018|605
Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy
|Cell stem cell|2016|565